PERFORMANCE AT A GLANCE

ME NAME

S.UMAR BASHA
Primary
Sales

Target
AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

CHENNAI
MONTH PERFORMANCE

8.47
7.59
7.95
24.01
9.96
9.68
8.54
28.18
7.58
9.24
10.49
27.31
10.23
7.66
5.32
23.21
102.71

11.4
8.49
6.33
26.22

0
26.22

Perf %

LY

134.6
111.9
79.6
109.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0

5.83
6.01

4.59
16.43
6.96
5.39
5.84
18.19
5.73
4.50
5.35
#DIV/0!

#DIV/0!
#DIV/0!

GR %

Secondary
Sales

96
7.48
41
8.94
38
6.89
60
23.31
-100
-100
-100
-100
0
-100
-100
-100
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

XYZ

YTD
Perf %

Closing
Inv

88.3
7.69
117.8 8.2
86.7
7.55
97.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
#DIV/0!
0.0
0.0
0.0
#DIV/0!
#DIV/0!

Target
8.47
16.06
24.01
48.54
33.97
43.65
52.19
129.81
59.77
69.01
79.5
208.28
89.73
97.39
102.71
289.83

Primary
Sales
11.4
19.88
26.33
57.61

Perf %
134.5927
123.7858
109.6626
118.7
0
0
0
0.0
0
0
0
0.0
0
0
0
0.0

COVERAGE
APR
DAYS WORKED
CALLS MADE
CALL AVG
Super Core Visits 4 & above
Super Core Visits 3
Super Core Visits 2
Super Core Visits 1
Super Core Missed
Core Visits 2 & more
Core 1 Visit
Core Missed
IMP 1 & >1 VISITS
IMP NO VISIT

MAY
25
240
9.6
22
0
41
14
9
0
0
14
11

25
229
9.1
19
5
36
19

19
19
4

JUN
26
229
8.8
23
1
1
0
0
38
5
6
19
6

JUL

AUG

SEPT

OCT

NOV

DEC

JAN

BRAND WISE PERFORMANCE

Glucoryl M
MONTH PERFORMANCE

AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

Target

Primary
Sales

Perf %

LY

GR %

3.97

3.97

4.70

118.4
86.0
89.0
98.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0

2.75

3.56

3.56

3.06

3.72
11.25
4.14
4.13
3.64
11.91
3.15
3.8
4.35
11.3
4.23
3.19
2.21
9.63
44.09

3.72
11.25
4.14
4.13
3.64
11.91
3.15
3.8
4.35
11.3
4.23
3.19
2.21
9.63
44.09

3.31
11.07

0
11.07

2.77

2.08
7.6
2.60
2.56
3.06
8.22
2.51
1.80
2.36
6.67

#DIV/0!
#DIV/0!

YTD

Secondary
Sales
71
10
59
46
-100
-100
-100
-100
-100
-100
-100
-100
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Perf %
3.94
3.69

3.36
10.99

-100

#DIV/0!
#DIV/0!

Closing
Inv
99.2
103.7
90.3
97.7
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-885.0
0.0
0.0
0.0
#DIV/0!
#DIV/0!

Target

Primary
Sales

3.97

4.70

7.52

7.76

11.24
22.73
15.38
19.51
23.15
58.04
26.3
30.1
34.45
90.85
38.68
41.87
44.08
124.63

11.48
23.94

Perf %
118.3879
103.1915
102.1352
105.3
0
0
0
0.0
0
0
0
0.0
0
0
0
0.0

Glucoryl MV
MONTH PERFORMANCE

AVG 15-16
April
May
June
Qtr 1

Target

Primary
Sales

2.73
2.45

3.14
2.69

2.56
7.74

1.81
7.64

Perf %

LY

GR %

115.0
109.8
70.7
98.7

1.49
1.27

111
112
46
91

1.24
4

YTD

Secondary
Sales
2.38
2.05

2.21
6.64

Perf %
87.2
83.7
86.3
85.8

Closing
Inv

Target

0.785

2.73

2.63

5.18
7.74
15.65

Primary
Sales
3.14
5.83

7.64
16.61

Perf %
115.0183
112.5483
98.70801
106.1

July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

2.85
2.84
2.5
8.19
2.17
2.62
3
7.79
2.91
2.19
1.52
6.62
30.34

0
7.64

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0

1.69
1.51
1.62
4.82
1.99
1.49
1.72
5.2

#DIV/0!
#DIV/0!

-100
-100
-100
-100
-100
-100
-100
-100
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

-100

#DIV/0!
#DIV/0!

0.0
0.0
0.0
0.0
0.0
0.0
0.0
-1283.7
0.0
0.0
0.0
#DIV/0!
#DIV/0!

10.59
13.43
15.93
39.95
18.1
20.72
23.72
62.54
26.63
28.82
30.34
85.79

0
0
0
0.0
0
0
0
0.0
0
0
0
0.0

Glucoryl Plain
MONTH PERFORMANCE
Target
AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

0.12
0.08
0.11
0.31
0.12
0.12
0.11
0.35
0.09
0.11
0.13
0.33
0.13
0.09
0.07
0.29
1.28

Voglikem group

Primary
Sales
0.1
0.07
0.03
0.2

0
0.2

Perf %

LY

GR %

83.3
87.5
27.3
64.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0

0.14
0.10
0.06
0.3

-29
-30
-50
-33
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

#DIV/0!

#DIV/0!
#DIV/0!

YTD

Secondary
Sales
0.05
0.17
0.08
0.3

#DIV/0!

#DIV/0!
#DIV/0!

Perf %
41.7
212.5
72.7
96.8
0.0
0.0
0.0
0.0
0.0
0.0
0.0
#DIV/0!
0.0
0.0
0.0
#DIV/0!
#DIV/0!

Closing
Inv
0.26
0.27
0.25

Target
0.12
0.2
0.31
0.63
0.43
0.55
0.66
1.64
0.75
0.86
0.99
2.6
1.12
1.21
1.28
3.61

Primary
Sales
0.1
0.17
0.2
0.47

Perf %
83.33333
85
64.51613
74.6
0
0
0
0.0
0
0
0
0.0
0
0
0
0.0

MONTH PERFORMANCE

AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

Target

Primary
Sales

1.04
0.93

1.66
1.64

0.97
2.94
1.08
1.08
0.95
3.11
0.82
0.99
1.14
2.95
1.11
0.83
0.58
2.52
11.52

0.74
4.04

0
4.04

Perf %

LY

GR %

159.6
176.3
76.3
137.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0

0.63
0.78

163
110
30
104
-100
-100
-100
-100
-100
-100
-100
-100
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

0.57
1.98
0.93
0.75
0.79
2.47
0.59
0.74
0.62
1.95

#DIV/0!
#DIV/0!

YTD

Secondary
Sales
1.20
1.93

0.74
3.87

-100

#DIV/0!
#DIV/0!

Perf %
115.4
207.5
76.3
131.6
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-3389.8
0.0
0.0
0.0
#DIV/0!
#DIV/0!

Closing
Inv
1.05
0.97
1.01

Target

Primary
Sales

1.04
1.97

1.66
3.30

2.94
5.95
4.02
5.1
6.05
15.17
6.87
7.86
9
23.73
10.11
10.94
11.52
32.57

4.04
9

Perf %
159.6154
167.5127
137.415
151.3
0
0
0
0.0
0
0
0
0.0
0
0
0
0.0

Rosukem group
MONTH PERFORMANCE

AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3

Target

Primary
Sales

0.40
0.33

1.04
0.53

0.35
1.08
0.39
0.39
0.34
1.12
0.3
0.36
0.41
1.07

0.33
1.9

Perf %

LY

GR %

260.0
160.6
94.3
175.9
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.20
0.42

420
26
-11
92
-100
-100
-100
-100
-100
-100
-100
-100

0.37
0.99
0.77
0.31
0.18
1.26
0.38
0.15
0.36
0.89

YTD

Secondary
Sales
0.39
0.88

0.29
1.56

-100

Perf %
97.5
266.7
82.9
144.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-9345.8

Closing
Inv
0.77
0.56
0.72

Target
0.40

0.73
1.08
2.21
1.47
1.86
2.2
5.53
2.5
2.86
3.27
8.63

Primary
Sales
1.04
1.57

1.9
4.51

Perf %
260
1.57

175.9259
204.1
0
0
0
0.0
0
0
0
0.0

Jan
Feb
Mar
Qtr 4
Annual Total

0.4
0.3
0.21
0.91
4.18

0
1.9

0.0
0.0
0.0
0.0
0

#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

0.0
0.0
0.0
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!

3.67
3.97
4.18
11.82

0
0
0
0.0

Zilokem group
MONTH PERFORMANCE
Target
AVG 15-16
April
May
June
Qtr 1
July
August
Sept
Qtr 2
Oct
Nov
Dec
Qtr 3
Jan
Feb
Mar
Qtr 4
Annual Total

Primary
Sales

0
0

Perf %
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

LY

#DIV/0!
#DIV/0!

GR %
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

YTD

Secondary
Sales

Perf %

Closing
Inv

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

#DIV/0!

#DIV/0!
#DIV/0!

Target

0
0
0
0
0
0
0
0
0
0
0
0
0
0

Primary
Sales

Perf %
#DIV/0!
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

INPUTS UTILIZATION
NAME OF INPUT

UNITS
APR

NANO MV LBL
QUALITY LBL
QUALITY REMINDER
ROSUKE SCIENTIFIC LBL
GOOD MORNING NESCAFE

40
40
100
20
18

MAY

JUN
40
40
60
20
12

JUL
30
40
30
20
18

AUG

NO OF UNIT DISTRIBUTED
SEP
OCT
NOV

BLOOD GLUCOSE REPORT

GOOD MORNING TETLEY TEA
ADD ON SCIENTIFIC LBL
GOOD MORNING REMINDER CARD
AD REMINDER NCARD
CHEMIST BOOK
GOOD ORNING GIFT1
GOOD MORNIG GIFT 2
GOOD MORNING GIFT 3
ROSUKEM 10 MG
GLUCORYL M1
GULCORYL M2
GULCORYL MV1 0.3
VOGLIKEM 0.2
VOGLIKEM 0.M0.3
ZILOKEM TEASER1
ZILOKEM TEASER 2
ZILOKEM TEASER 3

3
18
20
48
200
50
3
3
9
50
50
50
50
50
50
50
50
50

0
12
20
30
130
25
3
3
7
25
20
20
20
20
20

6
20

18
70
25

40

10
20
20
25
20
20
25
25
0

10
10
10
5
10
10
25
25
20

Campaigns
ACTIVITY
S No
1
2
3

DOCTOR'S NAME
DR K.P.PARATHASARATHY
DR R.KANNAN
DR K.SIDHARTHAN

SPEC
NAME
CONSULTIN
EL
DIABETOL
EL
CARDIO
EL

MONTH
BRANDS RXBING
VALUE
APRIL GLUCORYLM1, MV1, VOGLIKEM M FORTE
10K
APRIL GULCORYL M1, MV1, ROSUKEM 10 MG
10K
APRIL
GULCORYL2 MG, ROSUKEM 10 MG10K

APRIL
MAY
7000
3500
1000
1000
2500
2500

4
DR S.VICTOR
CONSULTIN
5
DR R.PRABAKAR JEGATHESAN
CONSULTIN
6
DR R.KAMALA KANNAN
CONSULTIN
7
R.SUNDAR
CARDIO
8
N.V. RAM MOHAN
DIABETOL
9
R.BALASUBRAMANIAM
DIABETOL
10
P.S. MOHAN MURUGAN
CARDIO
11
T.PALANIAPPAN
DIABETOL
12DDC CAMP AT DR A.PANNER SELVAMDIABETOLOGY
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

EL
EL
EL
EL
EL
EL
EL
EL

APRIL
GULCORYL M1, ROSUKEM 10MG 15K
APRIL GULCORYL M1, MV1, VOGLIKEM 0.2
10K
APRILGULCORYL M1 FORTE, MV1, VOGLIKEM
20K
0.2
APRIL GULCORYL M1, MV 1, VOGLILKEM 0.2
10K
APRIL
GULCORYL M1, ROSUKEM 10 MG10K
APRIL
GULCORYL M1, MV1,
15K
APRIL ROSUKEMM10, 20 MGGULCORYL M1,
25K
APRIL
GULCORYL M1, VOGLIKEM 0.3 50K
APRIL
CULCORYL M1, MV1, VOGLIKEM 0.2, M FORTE

4000
6000
6000
7000
2000
2000
5000
8000

5000
7000
6000
7000
2500
2000
7500
9000

PHYSICIAN CONVERSION
S No

DOCTOR'S NAME
1 VENKATESAN
2 GAJENDARAN

No of Pt POTENTIAL
PLACE
30
CHENNAI
1LAC
50
CHENNAI
2LAC

BRANDS RXBING
GLUCORYL M
VOGLIKEM

APR

MAY

3
4
5
6
7
8
9
10
11
12
13

M A BHAT
ARUMUGAM
MAHENDRAVERMAN
RS MURLIDARAN
L PARI
BHASKARAN W T
PRIYMALINI
SUGANANTHAN
PUSPHASARVANAN
GOPALKRISHNAN
KARUNANITHI

30
20
50
30
30
50
50
30
30
30
50

14 JHEYALALITHA

30

SANJAY
15 SRINIVASAN
16 PREMLATHA
17 K SRINIVAS

40
30
50

THIRUPATHI
19 RAJA
20 MS RAVI

30
30

21 MS MANOHAR

30

22 AHAMAD NAINA
23 N KANAN

50
40

24 BAKAVACHALLU

50

M SRINI M SRINIVASAN
B PALANI

40
50

1LAC
1LAC
2LAC
1LAC
1LAC
2LAC
2LAC
1LAC
1LAC
1LAC
2LAC
1LAC
2LAC
1LAC
2LAC
1LAC
1LAC
1LAC
2LAC
2LAC
2LAC
2LAC
2LAC

CHENNAI
CHENNAI
CHENNAI
CHENNAI
KOLATHUR
KOLATHUR
CHENNAI
CHENNAI
CHENNAI
CHENNAI
CHENNAI

ROSUKEM
GLUCORYL M
GLUCORYL M
ROSUKEM
VOGLIKEM
GLUCORYL M
GLUCORYL M
GLUCORYL M
VOGLIKEM
ROSUKEM
GLUCORYL M

CHENNAI

VOGLIKEM

CHENNAI
CHENNAI
CHENNAI

ROSUKEM
GLUCORYL M
GLUCORYL M

CHENNAI
CHENNAI

ROSUKEM
ROSUKEM

CHENNAI

GLUCORYL M

CHENNAI
CHENNAI

GLUCORYL M
ROSUKEM

CHENNAI

GLUCORYL M

CHENNAI
CHENNAI

ROSUKEM
GLUCORYL

RXBER WISE LIST

SPECIALITY
Endos
Diabetos

TOTAL DRS
3
25

TOTAL NUMBER OF RXBERS

APR
14

MAY

JUN
12

JULY
0
12

AUG

SEP

OCT

NOV

Cardios
CONS. PHY
GPs
Others
TOTAL DRS

10
35
20
5
98

3
15
8
0
40

3
12
8
0
35

3
12
8
0
35

INCENTIVES
SLAB
VALUE
QTR VALUE ACHIEVEMENT
CONSISTENCY INCENTIVE
Glucoryl M BRAND INCENTIVE
Glucoryl MV BRAND INCENTIVE
Voglikem BRAND INCENTIVE
Rosukem BRAND INCENTIVE
Zilokem BRAND INCENTIVE
STAR Awards
ACPL
TOTAL INCENTIVE

QTR I
EARNINGS

4000
250
1125
1125
2000

12000
750
3375
3375
6000

YES
5000

13110
500
0
0
6000

YES
5000
29750

0
19610

QTR II
EARNINGS

YTD PERFORMANCE
LY

GR %

5.83
11.84

96
68
60
69
-100
-100
-100
-100
-100
-100
-100
-300
-100
-100
-100
-300

16.43
34.1
23.39
28.78
34.62
86.79
40.35
44.85
50.2
#DIV/0!
50.2
50.2
50.2
#DIV/0!

FEB

MAR

Secondary
Sales
7.48
16.42

23.31
47.21

-100

-100

Perf %

Closing
Inv

88.3
0.95
102.2
1.656667
97.1
23.44
97.25999 26.04667
0.0
0
0.0
0
0.0
0
0
0
0.0
0
0.0
0
0.0
0
0
#DIV/0!
0.0
0
0.0
0
0.0
0
0
#DIV/0!

YTD PERFORMANCE
LY

GR %

2.75

71
30
42
42
-100
-100
-100
-100
-100
-100
-100
-300
-100
-100
-100
-300

5.99

8.07
16.81
8.07
8.07
8.07
24.21
8.07
8.07
8.07
24.21
8.07
8.07
8.07
#DIV/0!

Secondary
Sales
3.94
7.63

10.99
22.56

-100

-100

Perf %

Closing
Inv

99.2
101.5
97.8
99.25209
0.0
0.0
0.0
0
0.0
0.0
0.0
0
0.0
0.0
0.0
0

1.175
0.97
6.06
8.205
0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

Perf %

Closing
Inv

87.2
85.5
85.8
85.94249

0.785
0.72875
7.13
8.64375

YTD PERFORMANCE
LY

GR %

1.49

111
111
91
101

2.76
4
8.25

Secondary
Sales
2.38
4.43

6.64
13.45

5.69
7.2
8.82
21.71
10.81
12.3
14.02
#DIV/0!
14.02
14.02
14.02
#DIV/0!

-100
-100
-100
-100
-100
-100
-100
-300
-100
-100
-100
-300

-100

-100

0.0
0.0
0.0
0
0.0
0.0
0.0
0
0.0
0.0
0.0
0

0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

Perf %

Closing
Inv

41.7
110.0
96.8
90.47619
0.0
0.0
0.0
0
0.0
0.0
0.0
0
0.0
0.0
0.0
0

0.26
0.53
0.78
1.57
0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

YTD PERFORMANCE
LY

GR %

0.14
0.24
0.3
0.68
0.3
0.3
0.3
0.9
0.3
0.3
0.3
#DIV/0!
0.3
0.3
0.3
#DIV/0!

-29
-29
-33
-31
-100
-100
-100
-100
-100
-100
-100
-300
-100
-100
-100
-300

Secondary
Sales
0.05
0.22
0.3
0.57

-100

-100

YTD PERFORMANCE
LY

GR %

0.63
1.43

163
131
102
122
-100
-100
-100
-100
-100
-100
-100
-300
-100
-100
-100
-300

2
4.06
2.93
3.68
4.47
11.08
5.06
5.8
6.42
#DIV/0!
6.42
6.42
6.42
#DIV/0!

Secondary
Sales
1.20
3.13

3.87
8.2

-100

-100

Perf %

Closing
Inv

115.4
158.9
131.6
137.8151
0.0
0.0
0.0
0
0.0
0.0
0.0
0
0.0
0.0
0.0
0

1.05
2.02
3.03
6.1
0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

Perf %

Closing
Inv

97.5
174.0
144.4
145.7014
0.0
0.0
0.0
0
0.0
0.0
0.0
0

0.77
1.33
2.05
4.15
0
0
0
0
0
0
0
#DIV/0!

YTD PERFORMANCE
LY

GR %

0.20

420
153
92
149
-100
-100
-100
-100
-100
-100
-100
-300

0.62
0.99
1.81
1.76
2.07
2.25
6.08
2.63
2.78
3.14
#DIV/0!

Secondary
Sales
0.39

1.27
1.56
3.22

-100

3.14
3.14
3.14
#DIV/0!

-100
-100
-100
-300

-100

0.0
0.0
0.0
0

0
0
0
#DIV/0!

Perf %

Closing
Inv

YTD PERFORMANCE
LY

GR %

0
0
0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

DEC

JAN

Secondary
Sales

#DIV/0!

#DIV/0!

FEB

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

MAR

0
0
0
0
0
0
0
0
0
0
#DIV/0!
0
0
0
#DIV/0!

ROI
JUNE
JULY
7500
1000
3000

AUG

SEPT

OCT

5000
5000
4500
4000
2000
2000
5000
7000
1500

VALUE BUSINESS
JUNE

JULY

AUG

SEPT

OCT

1000

1500

1000

RS
DEC

JAN

FEB

MAR

R II
NINGS

QTR III
EARNINGS

QTR IV
EARNINGS